A timely review article in the International Journal of Diabetes and Technology addresses a critical yet underexplored question: how much does a person with diabetes actually spend on healthcare in India? Using an umbrella review approach, the author synthesizes evidence from existing systematic reviews to estimate an annual per-patient cost of approximately ₹20,660. Though preliminary, this figure starkly underscores the substantial economic burden diabetes places on individuals in a country often termed the “diabetes capital of the world.”

      Beyond the estimate, the article’s real strength lies in highlighting major evidence gaps, scarcity of high-quality cost studies, inconsistent methodologies, and lack of granular cost breakdowns. By transparently acknowledging limitations and calling for standardized, robust economic research, this review provides a strong foundation for future investigators and policymakers. It is a compelling reminder that tackling diabetes in India requires not only clinical innovation, but also clear economic evidence to drive equitable, affordable, and sustainable care.